e.g. regulation of cell volume, pH, Na + -coupled secondary transport of molecules and neurotransmitters, and the excitability of muscle and neuronal cells (1, 2) . In mammals, the four α (α 1 , α 2 , α 3 , α 4 ) isoforms display distinct tissue-specific expression patterns (2, 3) . The α 3 isoform (ATP1α 3 ) is expressed in brain, eye, ear, muscle, cartilage, uterus, placenta, and heart (4-7). In the brain, the ATP1α 3 subunit is present exclusively in neurons (8) . Mutations in the gene cause the neurological disorder rapid-onset dystonia-parkinsonism (RDP) (9, 10) , a rare movement disorder with an abrupt onset and rapid (hours to weeks) development of dystonia parkinsonism, primarily bradykinesia and postural instability (10, 11) .
Besides ion pump roles, Na + /K + -ATPases also serve as signal transducers, modulating synaptic plasticity, e.g. inducing dendritic growth in cortical neurons (12) . Evidence for neuronal roles of ATP1α 3 was previously found in both human and rat dorsal root ganglia (DRG), and also observed in rat embryos (E21) (13) .
Currently, two different genetically modified mouse models targeting the Atp1a3 gene exist: α 3 +/− KI I4 (14) and α 3 +/− KI I810N (Myshkin (Myk)) (15) . These mice display learning/memory deficits (14) , epilepsy/seizures (15) , stress-induced motor symptoms (16), anxious phenotype and depression-like behavior (17). However, they do not fully capture the human RDP symptoms, and the pathology of RDP remains unsolved.
Recently it became more evident that Danio rerio (zebrafish) is a valuable model for investigating Na + /K + -ATPase functions (18,19). We employed zebrafish, with its advantageous properties, e.g. external development with optical clarity, small size, short generation time (2-3 months) and high fecundity (20,21) to further study the role of ATP1α 3 in early neuronal functions. In a comparison of the zebrafish brain structure with human, the gross architecture of many zebrafish brain areas, e.g. retina, olfactory bulb, hypothalamus, cerebellum, and spinal cord, is similar to that of humans, although there exist some differences between teleosts and mammals (22). Moreover, zebrafish enables several behavioral and drug tests, hence is relevant for many disease-related studies.
Zebrafish have two ATP1Α3 orthologs, Atp1a3a and Atp1a3b (23) . Surprisingly, knockdown (KD) of Atp1a3a or Atp1a3b results in severe brain ventricle dilation in contrast to previous data where KD of Atp1a1 caused reduced brain ventricle inflation, thus supporting the role of Na + /K + -ATPase in brain ventricle development. The brain ventricle dilation in Atp1a3a/b-KD embryos was accompanied by a ~20 mV depolarization of the spinal Rohon-Beard (RB) neuron resting membrane potential (RMP), suggesting compromised functions in neurons as a consequence of Atp1a3a KD-generated defects in ion homeostasis. In support of this, morphant embryos further displayed both abnormal touch response and spontaneous movements. To identify additional neuronal functions that may depend on correct ion homeostasis for normal performance, we used a proteomic approach. Interestingly, this revealed several proteins, including cytoskeletal, ion binding, muscle associated proteins, etc., with expression levels that were affected by Atp1a3a or Atp1a3b KD. This is the first detailed report of α 3 Na + /K + -ATPases in zebrafish and on the basis of conservation of zebrafish and mammalian α 3 Na + /K + -ATPase expression and functions. Zebrafish can serve as an advantageous model for analysis of brain ventricular volume maintenance and embryonic motility, both related to ion homeostasis.
EXPERIMENTAL PROCEDURES
Animals-Tübingen (TU) zebrafish strain (Nüsslein-Volhard lab, Max Planck Institute, Tü-bingen, Germany) and Tg(gfap:GFP) transgenic line (Zebrafish International Resource Center, University of Oregon, USA) of either sex were used in the experiments. Embryo maintenance and staging were performed as previously described (24, 25) . To conserve optical clarity, embryos were raised in the presence of 0.2 mM 1-phenyl-2-thiourea (PTU) (24).
Reverse transcription (RT) and qRT-PCRqRT-PCR protocol was performed on cDNAs from embryos at corresponding stages (1k-cell, 50% epiboly, 75% epiboly, 6-somite, prim-6, prim-22, pec fin and adult (one male + one female)) as previously described (26). Pearl Primer software (27) and Roche assay design were used to design the primers (Table S2) 4 , accession numbers of which are provided in Table 1 . Generated PCR product sizes and iden-tities were verified by gel electrophoresis (data not shown) and DNA sequencing.
In order to investigate SP-MO-mediated KD, we initially performed RT-PCR using primers enclosing the presumably extruded exons. This clearly indicated that both SP-MOs caused a KD via nonsense-mediated mRNA decay (data not shown). The quantitation of KD levels was performed by qRT-PCR on 1 st strand cDNA generated from ~30 WT, std-MO (5.5, 11, 3 ng), α 3a -SP-MO (5.5, 11 ng) and α 3b -SP-MO (1.5, 3 ng) injected embryos.
Efficiency of each primer pair used in qRT-PCR was detected to be approximately 100%. Transcription levels were quantified using the relative quantification method based on comparative threshold cycle values (Ct).
Cloning of zebrafish Atp1a3a and Atp1a3b cDNA-Total RNA was isolated from a male and a female zebrafish by TRIzol ® method (Invitrogen) (28). Total RNA was used as template to perform RT-PCR by using SuperScript TM III RT-PCR system (Invitrogen) according to manufacturer's instructions with Atp1a3a and Atp1a3b specific primer pairs (Table S2 ) tagged with restriction enzyme recognition sites. The program for RT-PCR was 1 cycle for 30 min at 55°C and 2 min at 94°C followed by 40 cycles of 15 sec at 94°C, 30 sec at 66°C and 4 min at 68°C and a final extension for 15 min at 68°C. Gel purified RT-PCR fragments were cloned into pTZ57R vector (InsTAclone™ PCR Cloning Kit, Fermentas) following the manufacturers' protocol and subsequently subjected to DNA sequencing.
In situ hybridization and sectioning-Antisense and sense RNA probe templates were generated by PCR on pTZ57R vector harboring Atp1a3a probe coding sequence, for Atp1a3a; and by RT-PCR on adult zebrafish RNA, for Atp1a3b, introducing T7 priming site in both scenarios. Probes were Digoxigenin (DIG)-labeled during synthesis from purified PCR products by using the DIG RNA Labeling Mix (Roche) and T7 Polymerase (Roche) following the manufacturer's protocol. Embryos were fixed overnight in freshly prepared 4% paraformaldehyde (PFA) in phosphate buffered saline (PBS, pH 7.4) and kept in MetOH in -20ºC. To detect Atp1a3a and Atp1a3b transcripts, whole-mount in situ hybridization was performed on embryos at 60 hpf, as previously described (29) with minor modifications.
Embryos were embedded and oriented in 5% agar, so they could be cut transversely following dehydrating in ascending alcohol solutions (70% x2, 96% x2 and 99% x2), infiltration and embedding in glycolmethacrylate (Technovit 7100). Using a Microm 355, 20-µm-thick sections were cut and every tenth section was taken by systematic sampling.
Whole-mount embryos and sections were observed using an inverted microscope, Olympus IX71.
MO-mediated knockdown of Atp1a3a or Atp1a3b and mRNA rescue-MOs (Gene Tools, LLC) for microinjection were diluted in distilled water and microinjected into embryos at 1-4 cell stage. Translation blocking MOs: α 3a -MO (5'-CTTTCTTCAGTCTGTCAAACGGCGT-'3) (12 ng) and α 3b -MO (5'-AGAGTGATGGAGAAAGTGACAGCCT-'3) (3 ng); the splicing blocking MOs: α 3a -SP-MO (5'-TCCACCTGAGCAATGACACCAAACA-'3) (11 ng), targeting intron 6-exon 7 boundary, and α 3b -SP-MO (5'-AGTGCCTGACAGAAACAAAGCATTT-'3) (3 ng), targeting inton 7-exon 8 boundary; the standard control MO (std-MO: 5'-CCTCTTACCTCAGTTACAATTTATA-'3) (3, 12 ng); and the p53-MO (5'-GCGCCATTGCTTTGCAAGAATTG-'3) (4 ng) were injected at indicated amounts. Embryos were grown for 60 h in embryo medium with 0.003% PTU and observed under inverted microscope, Olympus IX71. In order to visualize zebrafish brain ventricles, rhodamine-conjugated dextran was injected into the brain ventricle at 48 hpf as previously described (30), and embryos were subsequently imaged under bright field and fluorescent light (Olympus IX71).
The template for Atp1a3a and Atp1a3b mRNA was generated by PCR on pTZ57R vector harbouring Atp1a3a (3069 bp) and Atp1a3b (3069 bp) coding sequences. In vitro synthesis of Atp1a3a and Atp1a3b mRNA was performed on gel purified Atp1a3a and Atp1a3b PCR products by using the mMessage mMachine T7 ULTRA kit (Ambion) following the manufacturer's instructions. The RNA products were gel purified (Qiagen) and each embryo was co-injected with 180 pg of WT Atp1a3a mRNA or 45 pg of WT Atp1a3b mRNA together with 11 ng α 3a -SP-MO or 3 ng α 3b -SP-MO, respectively. Embryos were assessed at 60 hpf, grouped morphologically into three classes depending on the severity of the brain Zebrafish Na pump maintains brain ventricle volume and motility ventricle dilation (+, slight/no; ++, moderate; +++, severe) (Fig. 2D, Whole-cell patch-clamp electrophysiologyAtp1a3a-Atp1a3a-KD and control embryos at 48 hpf were sacrificed, skinned and mounted dorsally to access to RB cells as previously described (32).
Atp1a3a-KD embryos were grouped into two according to brain ventricle dilation severity; ones with severe (+++) and slight/no (+) dilation. Electrodes were made to a tip resistance of 2.6-3.7 MΩ using a P-97 microelectrode puller (Sutter Instruments, Novato, CA) and filled with intracellular pipette solution (in mM: 135 KCl, 10 EGTA, and 10 HEPES; pH 7.4). RMP recordings were obtained from RB cells of these embryos together with WT and std-MO injected control embryos using patch electrodes and an Axopatch-200B amplifier (Axon Instruments, Molecular Devices,Sunnyvale, CA). Recordings were performed at room temperature, using bath solution (in mM: 125 NaCl, 3 KCl, 10 CaCl 2 , and 5 HEPES; pH 7.4) under inverted microscope Zeiss Axioskop (Germany). Data is presented as mean±s.e.m.
Touch response-Mechanosensory stimulation was delivered to the embryo trunk with a needle. WT, std-MO, α 3a -MO and α 3b -MO injected embryos with brain ventricle dilation phenotype at 60 hpf were recorded under an Olympus IX71 microscope at 25 frames/sec. Experiments were independently repeated at least three times.
Proteomics analysis by isobaric tags for relative and absolute quantitation (iTRAQ)-30-50 of std-MO, α 3a -MO, α 3b -MO injected embryos, 60 hpf, were collected in eppendorf tubes, were lysed in lysis buffer (0.02 M Tris, 0.137 M NaCl, 1% NP-40, 10% Glycerol, 1 mM PMSF, 1X complete Protease inhibitor cocktail tablet (Roche)) with the help of a homogenizor. Cell lysate was analyzed by iTRAQ LC-MS/MS as previously described (33). Briefly, the cell lysate was in-solution digested using trypsin; labeled with the iTRAQ (reporter ions m/z 114 and 115) followed by fractionation of the peptide mixture using hydrophilic interaction chromatography and LC-MS/MS analysis of the peptide fractions. Raw data files were processed using the Proteome Discoverer software (version 1.3) integrated with the MASCOT database search program (version 2.2.3). Data were searched against the nrDB database restricted to D. rerio.
RESULTS
Specific expression of Atp1a3a and Atp1a3b transcripts in the developing zebrafish brain-As an initial step to understand the roles of the α 3 Na + /K + -ATPases, we assessed expression of Atp1a3a and Atp1a3b mRNA by qRT-PCR. We detected the Atp1a3a transcript at the 1000-cell (1k cell; 3 hpf) and 50% epiboly (5.3 hpf) stages.
Zebrafish Na pump maintains brain ventricle volume and motility
Thereafter it declined and was barely detectable by 75% epiboly (8 hpf) and at the 6-somite (12 hpf) stage, suggesting that these early-detected transcripts were provided maternally. Atp1a3a reappeared at the prim-6 (25 hpf) and prim-22 (35 hpf) stages. The highest expression of Atp1a3a occurred at the pec fin stage (60 hpf), which was almost six-fold higher than the relative expression of the Atp1a3a transcript in adult zebrafish (Fig. 1A) . In contrast, the Atp1a3b mRNA was barely detectable from the 1000-cell to the 6-somite stage (Fig.  1A) , suggesting lack of maternal Atp1a3b contribution. Similar to Atp1a3a, the Atp1a3b transcript appeared at prim-6 and onwards, and also showed a marked increase at the pec fin stage (Fig. 1A) . Further experiments were performed at 48-60 hpf, due to the notable expression of both isoforms at these stages and the fact that the embryonic CNS is well structured by these stages. At these time points, the MO is still effective.
To determine whether of Atp1a3a and Atp1a3b transcripts were present in the central nervous system (CNS), we then performed in situ hybridization. The lack of antibody that detects the zebrafish α 3 isoforms did not allow us to directly test protein levels, however we assume that the detected transcripts give rise to protein products and represent active Na + /K + -ATPase pumps in the plasma membrane of the cell.
We showed that Atp1a3a transcripts localize to several CNS structures, including the epiphysis, tegmentum, tectum, cerebellum, cranial ganglia, hindbrain, and spinal cord ( In contrast to the widespread expression of Atp1a3a, the Atp1a3b transcript was detected in a more restricted but overlapping set of brain structures such as epiphysis, tegmentum, cranial ganglia, hindbrain and anterior spinal cord, evident in both lateral and dorsal views ( 
Knockdown of Atp1a3a causes brain ventricle dilation-To test for a role of the α 3a Na
+ /K + -ATPase in zebrafish development, we used an antisense MO oligonucleotide mediated KD approach. The translation-blocking MOs inhibit protein synthesis by binding to the translationinitiation site, while the splicing-blocking MOs bind to intron-exon boundaries and may inhibit proper splicing of the corresponding pre-mRNA, causing nonsense-mediated mRNA decay. In both MO approaches, we assume that the protein function is significantly reduced.
The efficiency of Atp1a3a-KD induced by α 3a -SP-MO was determined by qRT-PCR, demonstrating up to 62% reduction in the Atp1a3a transcript with increasing MO concentration (Fig. 2C) .
Marked brain ventricle dilation was observed upon KD of Atp1a3a using either translation-(α 3a -MO), or splice-blocking (α 3a -SP-MO) MOs ( Fig. 2A) , and was further visualized by rhodamine-conjugated dextran injection into zebrafish brain ventricles (Fig. 2B) . Use of the transgenic line, Tg(gfap:GFP), that expresses green fluorescent protein (GFP) in astrocytes provided an overall view of the CNS structure. A pressure to the brain structures from the ventricle dilation was evident upon Atp1a3a KD (Fig. 2B) . Injection of α 3a -SP-MO led to severe, moderate or slight/no brain ventricle dilation in 54%, 36% or 11% of embryos, respectively (Fig. 2D) , while std-MO injected embryos appeared morphologically normal ( Fig. 2A) .
To exclude that the observed brain ventricle dilation was caused by nonspecific MO-induced activation of p53-dependent apoptosis (34), control experiments were carried out: Co-injection of p53-MO with any of the MOs did not have an effect on the phenotype ( Fig. 2A) suggesting that p53-dependent effects, e.g. apoptosis, did not cause the phenotypes of Atp1a3a KD. To further confirm the specificity of the Atp1a3a-KD phenotypes, embryos were co-injected with in vitrosynthesized Atp1a3a mRNA. In the rescued embryos, the extent of the brain ventricle dilation was reduced compared to Atp1a3a-KD embryos, and severe, moderate and slight/no ventricle dilation was present in 21%, 29% and 50%, respectively (Fig. 2D) . Taken together, these findings suggest that Atp1a3a KD had specific effects that led to the brain ventricle dilation in α 3a and α 3a -SP MOinjected embryos.
Zebrafish Na pump maintains brain ventricle volume and motility
Atp1a3b deficient embryos phenocopy the Atp1a3a deficient embryos-We used a similar approach to assess the developmental role of the other ATP1A3 ortholog, Atp1a3b. qRT-PCR analysis showed that the α 3b -SP-MO led to reductions in transcript levels of 22% and 66% when injected in amounts of 1.5 ng and 3 ng, respectively (Fig.  3C) . Moreover, Atp1a3b-KD embryos showed brain ventricle dilation phenotype similar to those produced by Atp1a3a-KD embryos (Fig. 3A,B) . Atp1a3b KD caused severe brain ventricle dilation in 59%, moderate in 27%, and no extraordinary ventricle dilation in 14% of the embryos and std-MO injected embryos appeared morphologically normal (Fig. 3A,D) . Co-injections of p53-MO ruled out the activation of p53-dependent apoptosis in Atp1a3b-KD embryos (Fig. 3A) . Upon coinjection with in vitro transcribed Atp1a3b mRNA, severe brain ventricle dilation was observed in 16%, moderate in 24%, and no ventricle dilation in 61% of the embryos (Fig. 3D) . Importantly, the brain ventricle dilation of Atp1a3a-KD embryos was not rescued by co-injection of Atp1a3b mRNA, and conversely, Atp1a3b-KD embryos were not rescued by co-injection of Atp1a3a mRNA (Fig. 3E) .
The observation of similar phenotypes upon the use of two distinct MOs (Figs 2A,3A) , and the fact that the nonsense-mediated mRNA decay of the targeted transcript by SP-MOs could be observed in a concentration-correlated manner (Figs 2C,3C), together verified the specificity of the MOs used in this study. In addition, our observations of consistent brain ventricle dilation phenotypes, even after p53-MO co-injection with each MO (Figs 2A,3A) , and importantly, the significant rescue of the phenotypes by injection of the mRNA of the knocked down gene ( Figs 2D,3D) , further confirmed the specificity. It is important to note that full rescue of the brain ventricle dilation phenotype was not accomplished most likely due to limited stability of the injected exogenous mRNA in the cell.
Atp1a3a-KD leads to depolarization of the Rohon-Beard neurons resting membrane potential-RB cells are mechanosensory neurons localized in the dorsal spinal cord (35, 36) , and are involved in response to touch, a behavior that involves both neuronal and muscular components. RB neurons are within the domain of Atp1a3a expression (Fig. 1B) and accessible due to their superficial localization. Combining the advantages of Atp1a3a being expressed in RB neurons and the accessibility of these cells, we measured electrophysiological changes at the cellular level in RB neurons of Atp1a3a-KD embryos. The RMP of RB neurons was recorded using whole-cell patchclamp. The RMP of RB neurons in Atp1a3a-KD embryos displaying severe brain ventricle dilation was significantly (p<0.01) more depolarized (mean RMP: -46.6 ± 5.1 mV) compared to the RMP from slight/no brain ventricle dilationdisplaying Atp1a3a-KD embryos (mean RMP: -70.4 ± 2.9 mV), which were comparable (p>0.05) to the control groups, non-injected (mean RMP: -72.1 ± 1.7 mV) and std-MO injected (mean RMP: -65.2 ± 3.1 mV) embryos (Fig. 4A) .
A schematic representation illustrates the consequence of the depolarized RMP in RB neurons in an Atp1a3a-KD embryo (Fig. 4B) .
Atp1a3a-and Atp1a3b-KD embryos differ in their mechanosensory responses-The onset of Atp1a3a and Atp1a3b expression coincides with the ability of the embryo to respond to tactile stimulation at around 27 hpf (prim-6 stage), where a marked increase in the expression of both isoforms was detected (Fig. 1A) . Considering that RB cells mediate touch sensitivity for the embryo, and that KD of Atp1a3a depolarized the RB RMP, we tested for effects on tactile sensitivity. The RBmediated touch response is assayed by applying tactile stimuli to the trunk of a motile embryo (37) . Whereas, both Atp1a3a-and Atp1a3b-KD embryos display abnormal spontaneous motility (data not shown), they are motile and suitable for assessment of tactile sensitivity.
At 60 hpf, the control embryos, non-injected (Movie 1) and std-MO injected (Movie 2), responded by burst swimming as expected. Atp1a3a-KD embryos (Movie 3) typically responded quickly to tactile stimulation but with a brief escape and circling movements that in one instance culminated in convulsion (top). Atp1a3b KD also had a range of effects, some of which were similar to and others different from those produced by Atp1a3a KD (Movie 4). The most consistent difference was that Atp1a3b-KD embryos responded with a delay in contrast to the quick response of Atp1a3a-KD embryos. Similar to Atp1a3a-KD embryos, Atp1a3b-KD embryos also displayed brief distance recoils and, in one instance, convulsion (right). Successive frame shots from touch response movies (movie 1, 3 and 4) provide an overview of the embryonic movements and allow comparisons between the different experimental groups (Fig. 5) . Taken together, the data indicate that Atp1a3a or Atp1a3b KD impair but do not prevent embryonic motility. In addition, the embryos retain the ability to respond to touch but, given the motility defects, it was difficult to assess whether there was any reduction in touch sensitivity, although this is indicated by RMP alterations in RB neurons in Atp1a3a-KD and by delayed response in Atp1a3b-KD embryos.
Atp1a3a KD leads to disorganization of the brain but no loss of dopaminergic neurons-A subset of dystonia subtypes respond to L-DOPA treatments that target dopaminergic (DA) neurons in the substantia nigra (38) . However, RDP patients do not respond to L-DOPA treatment. To assess whether zebrafish α 3 isoforms differ in their association to DA neurons compared to their mammalian counterparts, we questioned the presence of zebrafish α 3 isoforms in DA neurons. Atp1a3a co-localized with the DA neuron marker, TH (Fig. 6A) , a marker previously used to identify DA neurons in zebrafish (39) . Confocal images highlight the classical arrangement of TH positive cells in the diencephalon, region that shows widespread expression of Atp1a3a mRNA (Fig. 6A) . The expression pattern of Atp1a3b (Fig. 1C) does not suggest co-expression of this isoform with DA neurons.
We then tested whether Atp1a3a KD affected DA neurons by comparing the distribution of Th transcripts in WT, α 3a -SP-MO-mediated Atp1a3a KD, and mRNA rescued Atp1a3a-KD embryos (Fig. 6B) . Whereas there were some slight differences in the pattern and intensity of the Th mRNA signal (Fig. 6B) , quantitative analysis showed no significant difference (Fig. 6C) . The variations in Th expression profile observed in Atp1a3a-KD zebrafish correlate with the extent of brain ventricle dilation and the consequent spatial reorganization in the brain, but not with loss of DA neurons. These results support the view that Atp1a3a KD does not lead to DA neuron degeneration.
Several proteins are up/down-regulated when either Atp1a3a or Atp1a3b is knocked down-In order to investigate the cellular protein networks that potentially involve α 3 Na + /K + -ATPases, we carried out proteomics analyses. Candidate proteins affected in Atp1a3a-or Atp1a3b-KD embryos were identified using isobaric tags for relative and absolute quantitation (iTRAQ), and listed together with their known tissue associations (Table S1 ). Interestingly, several candidates are of relevance to Na + /K + -ATPase and Atp1a3a-or Atp1a3b-KD phenotypes (Table  1) , but only selected candidates are discussed below. It is interesting to note that cytoskeletal and muscle associated proteins appear to be regulated by both α 3 isoforms. In contrast, the level of ion binding proteins and proteins involved in phosphate metabolism appear to depend on the α 3b isoform.
We performed qRT-PCR to verify selected proteomic candidates, as antibodies toward all of these zebrafish proteins were not available. We found that these transcripts were also downregulated in Atp1a3a or Atp1a3b-KD embryos, supporting the proteomics data at the transcript level (Fig. 7A,B) .
DISCUSSION
In this study, we analyzed zebrafish α 3 Na + /K + -ATPases to gain insight on specific functions of this particular ion pump and how we might use this model to elucidate the functions of the Na + /K + -ATPase in brain development. The Na + /K + -ATPase has a well-known role as a modulator of membrane potential in neurons and is essential for generating an action potential. Consistent with the mammalian ATP1α 3 expression, both ATP1A3 zebrafish orthologs are expressed primarily in the brain. Interestingly, the expression of the Atp1a3a mRNA is widely distributed in the brain, in contrast to a more restricted expression of the Atp1a3b mRNA, in line with the expression data available at The Zebrafish Model Organism Database (zfin.org). The Atp1a3a transcript was also abundant in the spinal cord and, to a lesser extent, in the heart. The latter observation is consistent with previous reports demonstrating ATP1α 3 expression in the neonatal, but not adult, rat heart (40, 41) .
Despite the distinct expression profiles of Atp1a3a and Atp1a3b transcripts, both Atp1a3a and Atp1a3b deficiencies cause brain ventricle dilation -rather than cellular swelling, indicating an altered fluid and electrolyte balance. Possibly, the subset of ventral CNS regions that express both Atp1a3a and Atp1a3b involves a pathological pathway that results in this phenotype A functional Na + /K + -ATPase, in a complex with aquaporins and glutamate transporters, is important for maintaining water and ion balance in the brain (42 (45) . Interestingly, a recent study showed that increases in aquaporin-1 (AQP1) and cation chloride transporters (Na + -K + -2Cl -cotransporter 1 (NKCC1)) expression under hyposmotic stress may be one of the molecular mechanisms underlying the pathophysiology of acute hyponatremia, by increasing water transport across the blood-CSF barrier (46) .
It is very interesting that the distinctively expressed α 3 isoforms both result in brain ventricle dilation when knocked down, and moreover, that they are not able to cross rescue. This indicates that at some level, the ion pump function must be the major mechanism behind our observations despite the different proteomic changes when knocked down. Furthermore, we do not know at this stage to what extent other Na + /K + -ATPase isoforms are active in the cells expressing these α 3 isoforms.
Modeling human diseases in other organisms requires complex analysis. Of particular relevance for this study is the fact that the water environment hosting zebrafish differs from other environments and thus requires other mechanisms for ion homeostasis to maintain osmolarity. However, we believe it is not so extraordinary to observe a brain ventricle dilation phenotype in the Atp1a3-KD zebrafish, although this is not a manifestation observed in RDP patients harboring mutations in the ATP1A3 gene (47) . Thus, we cannot rule out that the brain ventricle dilation is specific to zebrafish, despite the conserved functions of the Na + /K + -ATPase. The CSF fills the ventricle of the brain, the composition of the CSF influences neuronal activity, and it serves as a drainage pathway for the brain. The latter function might be significantly different in water-living animals. In summary, it appears that the α 3 Na + /K + -ATPase is a novel regulator of brain ventricle volume, at least in zebrafish.
Minor changes in ion composition in the extracellular and intracellular compartments of the brain can significantly affect neuronal function, which relies on precise ion gradients across their plasma membranes to trigger changes in membrane potentials underlying action potential generation and propagation. Therefore, ion and water transport in the brain are tightly regulated (48) . The most studied role of the α 3 isoform is its neuronal function, and failure of the Na + /K + -ATPase to maintain Na + and K + gradients leads to a decrease in both the RMP and the action potential, and to altered neuronal excitability in several different neurons, such as rat hippocampus dentate interneurons, pyramidal and purkinje neurons (49) . Consistent with this, we found that RB neurons had depolarized RMPs when Atp1a3a was knocked down. This result is important and additionally serves to strongly support the specificity of the Atp1a3-KD phenotypes. The change in the electrophysiological state of the RB neurons is thus predicted to alter the neuronal excitability, although future in vivo measurements of excitability are required to address this. Our data strongly supports a neuronal function for α 3 isoforms in zebrafish. We believe that it is important to keep in mind that the RMP recording is performed in RB neurons and the ventricle dilation is observed in the brain. We do not yet know the contributions from other Na + /K + -ATPase isoforms in these cell populations, and this could certainly explain why we could not demonstrate an altered RMP in the slight (if any) brain ventricle dilation-displaying embryos.
The production of any touch response in zebrafish can be divided into several steps from sensory perception to muscle activation. The mechanosensory neurons, in this case RB neurons, sense touch stimuli. Once triggered by sensory input, interneuronal networks located in the hindbrain and spinal cord produce the appropriate motor rhythm (50) . Depolarization in RB neurons, indicated abnormality in the sensory component of this type of behavior, although further experiments are needed to distinguish all the contributors of this phenotype. It is intriguing since the motor deficits observed in α 3 +/-KO mice were shown to have neuronal origin (16). Furthermore, inefficient central sensory-motor processing has been questioned to be a possible causative mechanism for dystonia, and numerous clinical phenomena suggest the primary involvement of the somatosensory system in this disorder (51, 52) .
Intriguingly, a recent study reported Na + /K + -ATPase as an important player in locomotor behavior of frog tadpoles (53) , and of Drosophila larvae (54) . Also, in spinal network of neonatal rats, blocking of Na + /K + pump activity disrupts rhythmic bursting of lumbar motor neurons (55, 56) . Moreover, the pump function of Na +/ K + -ATPase was recognized as a mechanism to gate sensory information entering the spinal cord, where it alters neuronal excitability (57) . By a similar mechanism, the changes in neuronal excitability might account for the impaired spontaneous motility of the Atp1a3a-and Atp1a3b-KD embryos.
Treatment of RDP patients with L-DOPA has no effect, and the DA re-uptake sites appear normal in such patients (58) . Although studies in mouse brain did not detect the α 3 isoform in DA neurons of substantia nigra (8) , it is interesting that another subunit, the beta subunit, ATP1β 1 , is down-regulated in DA neurons of patients with Parkinson´s disease (59) . We detected Atp1a3a expression in zebrafish TH-positive cells. In line with this, a recent study identified Atp1a3a as a target of a cardiac glycoside (a Na + /K + -ATPase inhibitor; Neriifolin), which impairs DA neuronal survival (60) . However, our results show that Atp1a3a KD does not result in loss of DA neurons in zebrafish, although we did observe reorganization in the DA neuron distribution profile. The latter is most likely caused by spatial restrictions due to the brain ventricle dilation, also noted in the Tg(gfap:GFP) Atp1a3a-and Atp1a3b-KD embryos.
We also identified novel proteomic changes associated with the α 3 isoform deficiencies. This is in fact the first time a proteomic approach is used to identify proteins up or down-regulated in ATP1α 3 -deficient cells. Interestingly, a recent study explored proteomic changes in ATP1α 2 -deficient zebrafish (18), and some of the regulated proteins, e.g. parvalbumin, muscle creatine kinase, published in that study, were also detected as regulated in Atp1a3b deficient embryos, indicating that the link between these proteins and the Na + /K + -ATPase is most likely dependent on the Na + /K + -ATPase pump function, rather than an isoform specific association. Hence, although preliminary, it provides an important initiative to be further assessed. To functionally address these candidate proteins in relation to the obtained Atp1a3a-and Atp1a3b-KD zebrafish and other animal models will be a future direction of this project.
Of particular interest is the down-regulation of parvalbumin detected in our proteomics assay of the Atp1a3a-KD embryos. Parvalbumin is expressed preferentially in a subpopulation of GABAergic neurons in mice, overlapping with the α 3 Na + /K + -ATPase expression (8, 61, 62) . Parvalbumin modulates short-term synaptic plasticity (63) , and thus compliments the signaling role of the α 3 Na + /K + -ATPase in synaptic plasticity and in dendritic growth in cortical neurons (64) . Neuronal associations of α 3 Na + /K + -ATPase are further supported by the down-regulation of guanidinoacetate methyltransferase (GAMT). The guanidinoacetate (GAA) is the principal metabolite accumulating in guanidinoacetate methyltransferase (GAMT) deficiency, which significantly inhibits Na + /K + -ATPase activity (65) . It was proposed that such inhibition may be one of the mechanisms involved in the neuronal dysfunction observed in patients suffering from GAMT deficiency, which shows symptoms comparable to RDP; e.g. muscle weakness, epilepsy and seizures (65, 66) .
Although it is clear that zebrafish embryos will not develop a full range of complex, humanlike disorders, they can be used to study certain biological markers (endophenotypes) of these disorders. Indeed, several features of zebrafish α 3 isoforms are comparable to the mammalian counterparts. This study comprehensively examined the spatial distribution of the zebrafish ATP1A3 orthologs and is the first report to show that the two distinctively expressed α 3 isoforms caused enlarged brain ventricle when gene functions were diminished. This was accompanied with abrupt embryonic motility, most likely linked to depolarized RMP, as shown for the spinal RB neurons, and this, combined with our proteomic data, highly promote zebrafish as a relevant model to further assess α 3 Na + /K + -ATPase in brain development, neuronal excitability, and thus functions. Doganli, C., Kjaer-Sorensen, K., Knoeckel, C., Beck, H. C., Nyengaard, J. R., Honore, B., Nissen, P., Ribera, A., Oxvig, C., and Lykke-Hartmann, K. (2012) Acknowledgments-We thank C. Knoeckel and R. Moreno, Department of Physiology and Biophysics, University of Colorado, Denver, for the assistance in whole-cell patch clamp electrophysiology recordings, and to J. R. Nyengaard, Aarhus University, Department of Biomedicine for the help on sectioning. Figure 6 Zebrafish Na pump maintains brain ventricle volume and motility
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